Centre René Huguenin

Saint-Cloud 92210

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer Metastatic, Gastrointestinal Stromal Tumors, T-cell Non-Hodgkin's Lymphoma

Studies at this site

• MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer. — Completed
• Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST) — Stopped early
• A Phase II Study of Single-Agent Lenalidomide in Subjects With Relapsed Or Refractory T-Cell Non-Hodgkin's Lymphoma — Stopped early